Outcomes and management of lenalidomide-associated rash in patients with multiple myeloma

International Consensus on drug allergy

(2014) P. Demoly et al.   ALLERGY

Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma

(2014) Min Jung Lee et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study

(2013) A. Larocca et al.   BLOOD

Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity

(2013) Alan G. Ramsay   BRITISH JOURNAL OF HAEMATOLOGY

Risk of Rash Associated With Lenalidomide in Cancer Patients: A Systematic Review of the Literature and Meta-analysis

(2013) Beatrice Nardone et al.   Clinical Lymphoma Myeloma & Leukemia

Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects

(2013) Annalisa Patrizi et al.   Cutaneous and Ocular Toxicology

Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy

(2013) J Shortt et al.   ONCOGENE

Lenalidomide-induced photosensitivity

(2013) María Genma Pérez-Paredes et al.   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

(2013) J. Kronke et al.   SCIENCE

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

(2013) G. Lu et al.   SCIENCE

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors

(2012) Yevgeniy Balagula et al.   CANCER

Lenalidomide enhances anti-myeloma cellular immunity

(2012) Katarina Luptakova et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

(2012) D. A. Ostrov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602

(2011) Giuseppa Penna et al.   ACTA ONCOLOGICA

Lenalidomide-Induced Acute Acneiform Folliculitis of the Head and Neck: Not Only the Anti-EGF Receptor Agents

(2009) Carine Michot et al.   DERMATOLOGY

Erythema Multiforme/Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in Lenalidomide-Treated Patients

(2008) Carmen P. Castaneda et al.   JOURNAL OF CLINICAL ONCOLOGY